Literature DB >> 25220734

Distortion of memory Vδ2 γδ T cells contributes to immune dysfunction in chronic HIV infection.

Zhen Li1, Yanmei Jiao2, Yu Hu1, Lianxian Cui1, Dexi Chen3, Hao Wu2, Jianmin Zhang1, Wei He1.   

Abstract

γδ T cells play important roles in innate immunity as the first-line of defense against infectious diseases. Human immunodeficiency virus (HIV) infection disrupts the balance between Vδ(1) T cells and Vδ(2) T cells and causes dysfunction among γδ T cells. However, the biological mechanisms and clinical consequences of this disruption require further investigation. In this study, we performed a comprehensive analysis of phenotype and function of memory γδ T cells in cohorts of Chinese individuals with HIV infection. We found a dynamic change in memory Vδ(2) γδ T cells, skewed toward an activated and terminally differentiated effector memory phenotype T(EMRA) Vδ(2) γδ T cell, which may account for the dysfunction of Vδ(2) γδ T cells in HIV disease. In addition, we found that IL-17-producing γδ T cells were significantly increased in HIV-infected patients with fast disease progression and positively correlated with HLA-DR(+) γδ T cells and CD38(+)HLA-DR(+) γδ T cells. This suggests the IL-17 signaling pathway is involved in γδ T-cell activation and HIV pathogenesis. Our findings provide novel insights into the role of Vδ(2) T cells during HIV pathogenesis and represent a sound basis on which to consider immune therapies with these cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25220734      PMCID: PMC4579648          DOI: 10.1038/cmi.2014.77

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  48 in total

1.  Association between peripheral γδ T-cell profile and disease progression in individuals infected with HIV-1 or HIV-2 in West Africa.

Authors:  Natalie N Zheng; M Juliana McElrath; Papa Salif Sow; Andrew Mesher; Stephen E Hawes; Joshua Stern; Geoffrey S Gottlieb; Stephen C De Rosa; Nancy B Kiviat
Journal:  J Acquir Immune Defic Syndr       Date:  2011-06-01       Impact factor: 3.731

2.  Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA.

Authors:  Silvia Baroncelli; Clementina Maria Galluzzo; Maria Franca Pirillo; Maria Grazia Mancini; Liliana Elena Weimer; Mauro Andreotti; Roberta Amici; Stefano Vella; Marina Giuliano; Lucia Palmisano
Journal:  J Clin Virol       Date:  2009-09-25       Impact factor: 3.168

3.  Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions.

Authors:  Christine A Jansen; Iris M De Cuyper; Radjin Steingrover; Suzanne Jurriaans; Sanjay U C Sankatsing; Jan M Prins; Joep M A Lange; Debbie van Baarle; Frank Miedema
Journal:  AIDS       Date:  2005-07-22       Impact factor: 4.177

4.  CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis.

Authors:  Jean-Philippe Herbeuval; Jean-Charles Grivel; Adriano Boasso; Andrew W Hardy; Claire Chougnet; Matthew J Dolan; Hideo Yagita; Jeffrey D Lifson; Gene M Shearer
Journal:  Blood       Date:  2005-07-26       Impact factor: 22.113

5.  Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Authors:  Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek
Journal:  J Infect Dis       Date:  2011-01-20       Impact factor: 5.226

6.  Imbalanced production of cytokines by T cells associates with the activation/exhaustion status of memory T cells in chronic HIV type 1 infection.

Authors:  Kaori Nakayama; Hitomi Nakamura; Michiko Koga; Tomohiko Koibuchi; Takeshi Fujii; Toshiyuki Miura; Aikichi Iwamoto; Ai Kawana-Tachikawa
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-23       Impact factor: 2.205

Review 7.  Natural T cell immunity to intracellular pathogens and nonpeptidic immunoregulatory drugs.

Authors:  F Poccia; C Agrati; G Ippolito; V Colizzi; M Malkovsky
Journal:  Curr Mol Med       Date:  2001-03       Impact factor: 2.222

8.  The γδ T-cell receptor repertoire is reconstituted in HIV patients after prolonged antiretroviral therapy.

Authors:  Suchita Chaudhry; Cristiana Cairo; Vanessa Venturi; C David Pauza
Journal:  AIDS       Date:  2013-06-19       Impact factor: 4.177

9.  The NKG2D ligand ULBP4 binds to TCRgamma9/delta2 and induces cytotoxicity to tumor cells through both TCRgammadelta and NKG2D.

Authors:  Yan Kong; Wei Cao; Xueyan Xi; Chi Ma; Lianxian Cui; Wei He
Journal:  Blood       Date:  2009-05-12       Impact factor: 22.113

10.  Critical roles for Akt kinase in controlling HIV envelope-mediated depletion of CD4 T cells.

Authors:  Haishan Li; C David Pauza
Journal:  Retrovirology       Date:  2013-06-06       Impact factor: 4.602

View more
  10 in total

1.  In Human Immunodeficiency Virus primary infection, early combined antiretroviral therapy reduced γδ T-cell activation but failed to restore their polyfunctionality.

Authors:  Rita Casetti; Alessandra Sacchi; Veronica Bordoni; Germana Grassi; Eleonora Cimini; Francesca Besi; Carmela Pinnetti; Annalisa Mondi; Andrea Antinori; Chiara Agrati
Journal:  Immunology       Date:  2019-07-08       Impact factor: 7.397

2.  Syphilis Infection Differentially Regulates the Phenotype and Function of γδ T Cells in HIV-1-Infected Patients Depends on the HIV-1 Disease Stage.

Authors:  Zhen Li; Xiaofan Lu; Zhiliang Hu; Zhenwu Luo; Wei Jiang; Hao Wu; Yanqing Gao; Junling Yan; Qiuyue Zhang; Aixin Song; Xiaojie Huang; Danlei Mou; Bin Su; Tong Zhang
Journal:  Front Immunol       Date:  2017-08-21       Impact factor: 7.561

3.  Synergistic effect of IL-12 and IL-18 induces TIM3 regulation of γδ T cell function and decreases the risk of clinical malaria in children living in Papua New Guinea.

Authors:  Louis Schofield; Lisa J Ioannidis; Stephan Karl; Leanne J Robinson; Qiao Y Tan; Daniel P Poole; Inoni Betuela; Danika L Hill; Peter M Siba; Diana S Hansen; Ivo Mueller; Emily M Eriksson
Journal:  BMC Med       Date:  2017-06-15       Impact factor: 8.775

Review 4.  γδ T-cell responses during HIV infection and antiretroviral therapy.

Authors:  Jennifer A Juno; Emily M Eriksson
Journal:  Clin Transl Immunology       Date:  2019-07-17

Review 5.  What Can Gamma Delta T Cells Contribute to an HIV Cure?

Authors:  Jennifer A Juno; Stephen J Kent
Journal:  Front Cell Infect Microbiol       Date:  2020-05-19       Impact factor: 5.293

Review 6.  The Roles of γδ T Cells in Hematopoietic Stem Cell Transplantation.

Authors:  Wanyi Ye; Xueting Kong; Wenbin Zhang; Zheng Weng; Xiuli Wu
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

Review 7.  The Role of Innate Immunity in Natural Elite Controllers of HIV-1 Infection.

Authors:  Yuting Shi; Jinming Su; Rongfeng Chen; Wudi Wei; Zongxiang Yuan; Xiu Chen; Xinwei Wang; Hao Liang; Li Ye; Junjun Jiang
Journal:  Front Immunol       Date:  2022-02-08       Impact factor: 7.561

8.  Potential Role of Vδ2+ γδ T Cells in Regulation of Immune Activation in Primary HIV Infection.

Authors:  Nupur Bhatnagar; Pierre-Marie Girard; Moises Lopez-Gonzalez; Céline Didier; Lio Collias; Corinne Jung; Diane Bollens; Claudine Duvivier; Cassandre Von Platen; Daniel Scott-Algara; Laurence Weiss
Journal:  Front Immunol       Date:  2017-09-25       Impact factor: 7.561

9.  Detection of Cell Surface Ligands for Human Synovial γδ T Cells.

Authors:  Cheryl Collins; Yuan Lui; Ana Mafalda Santos; Bryan A Ballif; Anisha Mahalya Gogerly-Moragoda; Heather Brouwer; Robin Ross; Kuberan Balagurunathan; Sumana Sharma; Gavin J Wright; Simon Davis; Ralph C Budd
Journal:  J Immunol       Date:  2019-09-23       Impact factor: 5.422

10.  The phenotypic changes of γδ T cells in COVID-19 patients.

Authors:  Lei Lei; Hongbo Qian; Xiaofang Yang; Xingzhe Zhang; Dan Zhang; Tongxin Dai; Rui Guo; Lin Shi; Yanbin Cheng; Baojun Zhang; Xiaobo Zhou; Jinsong Hu; Yaling Guo
Journal:  J Cell Mol Med       Date:  2020-08-30       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.